Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Aarti Industries reports 17% EBITDA growth in Q3 FY25 amid strong volume performance Aarti Industries Limited (AIL), a leading player in the speciality chemicals market, has posted a 17% sequential rise… byPallavi MadhirajuFebruary 2, 2025